tldrdailynews.com logo

Novo Nordisk Cuts Ozempic Price to $499 for Cash Patients

1 min read
Source: Financial Times
Novo Nordisk Cuts Ozempic Price to $499 for Cash Patients
Photo: Financial Times
TL;DR

Novo Nordisk has halved the US price of Ozempic, a popular diabetes medication, as part of its efforts to improve accessibility and address concerns over drug pricing.

Topics:top-newsbusiness#business#diabetes-medication#novo-nordisk#ozempic#pharmaceutical-pricing#us-price-reduction
Share this article
  1. Novo Nordisk halves US price of Ozempic  Financial Times
  2. Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients  CNBC
  3. GoodRx stock soars after striking deal to sell Novo Nordisk's GLP-1s for $499/month  Yahoo Finance
  4. Novo Halves Ozempic Price to $499 a Month for Those Paying Cash  Bloomberg.com
  5. GoodRx Announces Collaboration with Novo Nordisk to Expand Access to Ozempic  Business Wire

Want the full story? Read the original reporting

Read on Financial Times